MoonLake Immunotherapeutics (MLTX) Stock Analysis

MoonLake Immunotherapeutics (MLTX) is a publicly traded company in the HEALTHCARE sector. It trades at $17.87, carries a market capitalization of $1.39B. This page summarizes the public market data, fundamentals, and frequently asked questions for MLTX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $17.87
• Market Cap: $1.39B
• EPS: $-3.88
• 52-Week High: $62.75
• 52-Week Low: $5.95

Market Sentiment

MoonLake Immunotherapeutics currently has a Neutral sentiment score of -0.05.

About MoonLake Immunotherapeutics

None

GNG Research Analysis

GNG Research scores MoonLake Immunotherapeutics (MLTX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for MLTX.

Frequently Asked Questions

Does MLTX pay dividends?

MoonLake Immunotherapeutics (MLTX) does not currently pay a regular dividend.

What is MLTX's market cap?

MoonLake Immunotherapeutics (MLTX) has a market capitalization of $1.39B with a current stock price of $17.87.